vs
ExlService Holdings, Inc.（EXLS）とSotera Health Co（SHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
ExlService Holdings, Inc.の直近四半期売上が大きい（$542.6M vs $303.4M、Sotera Health Coの約1.8倍）。Sotera Health Coの純利益率が高く（11.5% vs 11.1%、差は0.4%）。ExlService Holdings, Inc.の前年同期比売上増加率が高い（12.7% vs 4.6%）。ExlService Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$106.5M vs $52.4M）。過去8四半期でExlService Holdings, Inc.の売上複合成長率が高い（11.5% vs 10.6%）
ExlService Holdings Inc.は保険、ヘルスケア、銀行・金融サービス、メディア、小売などの業界を対象に分析・デジタルソリューションを提供するグローバル企業で、本社はニューヨークに所在し、米国、欧州、アジア、中南米、オーストラリア、南アフリカなど世界各地に5万4000人以上の専門スタッフを擁しています。
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
EXLS vs SHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $542.6M | $303.4M |
| 純利益 | $60.2M | $34.8M |
| 粗利率 | 38.6% | 54.7% |
| 営業利益率 | 14.4% | 23.2% |
| 純利益率 | 11.1% | 11.5% |
| 売上前年比 | 12.7% | 4.6% |
| 純利益前年比 | 18.9% | 182.8% |
| EPS（希薄化後） | $0.38 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $542.6M | $303.4M | ||
| Q3 25 | $529.6M | $311.3M | ||
| Q2 25 | $514.5M | $294.3M | ||
| Q1 25 | $501.0M | $254.5M | ||
| Q4 24 | $481.4M | $290.2M | ||
| Q3 24 | $472.1M | $285.5M | ||
| Q2 24 | $448.4M | $276.6M | ||
| Q1 24 | $436.5M | $248.2M |
| Q4 25 | $60.2M | $34.8M | ||
| Q3 25 | $58.2M | $48.4M | ||
| Q2 25 | $66.1M | $8.0M | ||
| Q1 25 | $66.6M | $-13.3M | ||
| Q4 24 | $50.7M | $12.3M | ||
| Q3 24 | $53.0M | $17.0M | ||
| Q2 24 | $45.8M | $8.8M | ||
| Q1 24 | $48.8M | $6.3M |
| Q4 25 | 38.6% | 54.7% | ||
| Q3 25 | 38.5% | 57.0% | ||
| Q2 25 | 37.7% | 56.6% | ||
| Q1 25 | 38.6% | 53.2% | ||
| Q4 24 | 38.1% | 56.6% | ||
| Q3 24 | 37.8% | 55.4% | ||
| Q2 24 | 37.1% | 55.2% | ||
| Q1 24 | 37.4% | 51.2% |
| Q4 25 | 14.4% | 23.2% | ||
| Q3 25 | 14.4% | 23.4% | ||
| Q2 25 | 15.8% | 6.4% | ||
| Q1 25 | 15.7% | -5.8% | ||
| Q4 24 | 14.8% | 30.0% | ||
| Q3 24 | 14.7% | 28.2% | ||
| Q2 24 | 13.7% | 27.8% | ||
| Q1 24 | 14.1% | 21.4% |
| Q4 25 | 11.1% | 11.5% | ||
| Q3 25 | 11.0% | 15.5% | ||
| Q2 25 | 12.8% | 2.7% | ||
| Q1 25 | 13.3% | -5.2% | ||
| Q4 24 | 10.5% | 4.2% | ||
| Q3 24 | 11.2% | 6.0% | ||
| Q2 24 | 10.2% | 3.2% | ||
| Q1 24 | 11.2% | 2.5% |
| Q4 25 | $0.38 | $0.12 | ||
| Q3 25 | $0.36 | $0.17 | ||
| Q2 25 | $0.40 | $0.03 | ||
| Q1 25 | $0.40 | $-0.05 | ||
| Q4 24 | $0.31 | $0.05 | ||
| Q3 24 | $0.33 | $0.06 | ||
| Q2 24 | $0.28 | $0.03 | ||
| Q1 24 | $0.29 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $328.4M | $344.6M |
| 総負債低いほど良い | $298.6M | $2.1B |
| 株主資本純資産 | $912.7M | $606.0M |
| 総資産 | $1.7B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.33× | 3.53× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $328.4M | $344.6M | ||
| Q3 25 | $390.1M | $299.2M | ||
| Q2 25 | $353.3M | $332.4M | ||
| Q1 25 | $331.4M | $304.4M | ||
| Q4 24 | $340.6M | $277.2M | ||
| Q3 24 | $325.8M | $306.7M | ||
| Q2 24 | $276.1M | $246.1M | ||
| Q1 24 | $246.2M | $261.1M |
| Q4 25 | $298.6M | $2.1B | ||
| Q3 25 | $354.8M | $2.1B | ||
| Q2 25 | $260.0M | $2.2B | ||
| Q1 25 | $307.3M | $2.2B | ||
| Q4 24 | $288.5M | $2.2B | ||
| Q3 24 | $344.7M | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $912.7M | $606.0M | ||
| Q3 25 | $952.4M | $550.5M | ||
| Q2 25 | $1.1B | $511.3M | ||
| Q1 25 | $1.0B | $414.1M | ||
| Q4 24 | $929.9M | $404.9M | ||
| Q3 24 | $907.6M | $470.2M | ||
| Q2 24 | $852.6M | $422.8M | ||
| Q1 24 | $803.3M | $429.4M |
| Q4 25 | $1.7B | $3.3B | ||
| Q3 25 | $1.7B | $3.2B | ||
| Q2 25 | $1.7B | $3.2B | ||
| Q1 25 | $1.7B | $3.1B | ||
| Q4 24 | $1.6B | $3.1B | ||
| Q3 24 | $1.6B | $3.1B | ||
| Q2 24 | $1.5B | $3.1B | ||
| Q1 24 | $1.4B | $3.1B |
| Q4 25 | 0.33× | 3.53× | ||
| Q3 25 | 0.37× | 3.89× | ||
| Q2 25 | 0.25× | 4.34× | ||
| Q1 25 | 0.30× | 5.36× | ||
| Q4 24 | 0.31× | 5.49× | ||
| Q3 24 | 0.38× | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $117.4M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $106.5M | $52.4M |
| FCFマージンFCF / 売上 | 19.6% | 17.3% |
| 設備投資強度設備投資 / 売上 | 2.0% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | 1.95× | 2.96× |
| 直近12ヶ月FCF直近4四半期 | $298.1M | $149.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $117.4M | $103.1M | ||
| Q3 25 | $120.7M | $71.2M | ||
| Q2 25 | $109.4M | $57.4M | ||
| Q1 25 | $3.2M | $55.5M | ||
| Q4 24 | $105.3M | $55.7M | ||
| Q3 24 | $110.1M | $97.5M | ||
| Q2 24 | $74.9M | $61.3M | ||
| Q1 24 | $-21.9M | $9.7M |
| Q4 25 | $106.5M | $52.4M | ||
| Q3 25 | $106.4M | $35.0M | ||
| Q2 25 | $95.0M | $26.2M | ||
| Q1 25 | $-9.7M | $35.6M | ||
| Q4 24 | $95.3M | $-10.2M | ||
| Q3 24 | $97.3M | $61.1M | ||
| Q2 24 | $62.8M | $19.4M | ||
| Q1 24 | $-33.1M | $-25.2M |
| Q4 25 | 19.6% | 17.3% | ||
| Q3 25 | 20.1% | 11.2% | ||
| Q2 25 | 18.5% | 8.9% | ||
| Q1 25 | -1.9% | 14.0% | ||
| Q4 24 | 19.8% | -3.5% | ||
| Q3 24 | 20.6% | 21.4% | ||
| Q2 24 | 14.0% | 7.0% | ||
| Q1 24 | -7.6% | -10.2% |
| Q4 25 | 2.0% | 16.7% | ||
| Q3 25 | 2.7% | 11.6% | ||
| Q2 25 | 2.8% | 10.6% | ||
| Q1 25 | 2.6% | 7.8% | ||
| Q4 24 | 2.1% | 22.7% | ||
| Q3 24 | 2.7% | 12.7% | ||
| Q2 24 | 2.7% | 15.2% | ||
| Q1 24 | 2.6% | 14.1% |
| Q4 25 | 1.95× | 2.96× | ||
| Q3 25 | 2.08× | 1.47× | ||
| Q2 25 | 1.66× | 7.21× | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 2.08× | 4.52× | ||
| Q3 24 | 2.08× | 5.73× | ||
| Q2 24 | 1.63× | 7.00× | ||
| Q1 24 | -0.45× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
